chr17:37868196:> Detail (hg19) (ERBB2)

Information

Genome

Assembly Position
hg19 chr17:37,868,196-37,881,332
hg38 chr17:39,711,943-39,725,079 

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
bladder carcinoma Platinum Compound C Predictive Supports Sensitivity/Response Somatic 3 25636205 Detail
breast cancer Neratinib B Predictive Supports Sensitivity/Response Somatic 4 28679771 Detail
lung non-small cell carcinoma Pertuzumab,Trastuzumab B Predictive Supports Sensitivity/Response Somatic 2 29320312 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
In patients with muscle-invasive bladder chancer, a cohort of complete responders to platinum chemot... CIViC Evidence Detail
16 patients with HER2-mutated metastatic breast cancer were treated with neratinib monotherapy. Of t... CIViC Evidence Detail
The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr17:37,868,196-37,881,332
Variant Type
snv
Variant (CIViC) (CIViC Variant)
MUTATION
Transcript 1 (CIViC Variant)
ENST00000269571.5
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/666
Genome browser